ZINC AS ADJUNCT THERAPY IN DEPRESSION - A LITERATURE REVIEW OF CLINICAL BENEFITS AND BIOCHEMICAL MECHANISMS
PDF (Português (Brasil))

Keywords

Depression; Zinc; Supplementation; Adjuvant treatment; Micronutrients; Clinical efficacy; Neuroplasticity.

How to Cite

Arashiro, H. S., Pieroni , L. D., Almeida , G. de P., Cechelero , N. J. S., Sartori, B. M., Jatene, W. S., Nicola, A. H., Vezaro , L. H. S., Carvalho, M. E. A. de, Toledo, E. M. de, Mello, G. L. e S. de, & Spirlandelli, M. L. (2024). ZINC AS ADJUNCT THERAPY IN DEPRESSION - A LITERATURE REVIEW OF CLINICAL BENEFITS AND BIOCHEMICAL MECHANISMS. Brazilian Journal of Implantology and Health Sciences, 6(7), 2790–2901. https://doi.org/10.36557/2674-8169.2024v6n7p2790-2901

Abstract

Objective: This study aimed to review the clinical aspects and underlying biological mechanisms of zinc supplementation's efficacy in treating depression, with a particular focus on the benefits observed in patients who do not adequately respond to conventional treatments.

Results: Of the initially found articles, 15 were selected based on their relevance and methodological quality. These studies suggest that zinc may play a significant role in improving depressive symptoms, primarily through the modulation of biological mechanisms such as neuroplasticity and synaptic function, interaction with the hypothalamic-pituitary-adrenal (HPA) axis, and potentially increasing brain-derived neurotrophic factor (BDNF) levels.

Conclusion: Zinc supplementation appears to be a promising intervention in the treatment of depression, particularly beneficial for patients resistant to traditional treatments. The results indicate that zinc may improve depressive symptoms through a range of biological mechanisms. However, further research is needed to define the optimal dosages and duration of treatment, as well as to fully elucidate the mechanisms by which zinc exerts its therapeutic effects. Prevention through adequate supplementation and early treatment may be effective strategies to improve the quality of life for patients.

https://doi.org/10.36557/2674-8169.2024v6n7p2790-2901
PDF (Português (Brasil))

References

Swardfager W, Herrmann N, McIntyre RS, Mazereeuw G, Goldberger K, Cha DS, et al. Potential roles of zinc in the pathophysiology and treatment of major depressive disorder. Neurosci Biobehav Rev. 2013 Jun;37(5):911-29.

Szewczyk B, Poleszak E, Sowa-Kucma M, Siwek M, Dudek D, Ryszewska-Pokraśniewicz B, et al. Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep. 2008 Sep-Oct;60(5):588-9.

Petrilli M, Kranz TM, Kleinhaus K, Joe P, Getz M, Johnson P, et al. The Emerging Role for Zinc in Depression and Psychosis. Front Pharmacol. 2017;8:414.

Nowak G, Szewczyk B, Pilc A. Zinc and depression. An update. Pharmacol Rep. 2005;57(6):713-8.

Ranjbar E, Shams J, Sabetkasaei M, M-Shirazi M, Rashidkhani B, Mostafavi A, et al. Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression. Nutr Neurosci. 2014;17(2):65-71.

Nowak G, Siwek M, Dudek D, Zięba A, Pilc A. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol. 2003;55(6):1143-7.

Lai J, Moxey A, Nowak G, Vashum K, Bailey K, McEvoy M. The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials. J Affect Disord. 2012 Jan;136(1-2):e31-9.

Tassabehji NM, Corniola RS, Alshingiti A, Levenson CW. Zinc deficiency induces depressionlike symptoms in adult rats. Physiol Behav. 2008;95(3):365-9.

Whittle N, Lubec G, Singewald N. Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids. 2009 Jan;36(1):147-58.

Siwek M, Dudek D, Paul IA, Sowa-Kucma M, Zięba A, Popik P, et al. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebocontrolled study. J Affect Disord. 2009 Nov;118(1-3):187-95.

Szewczyk B, Kubera M, Nowak G. The role of zinc in neurodegenerative inflammatory pathways in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr;35(3):693-701.

Nowak G, Szewczyk B, Wieronska JM, Branski P, Palucha A, Pilc A, et al. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull. 2003 Jul 15;61(2):159-64.

Siwek M, Dudek D, Schlegel-Zawadzka M, Morawska A, Piekoszewski W, Opoka W, et al. Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord. 2010 Dec;126(3):447-52.

Swardfager W, Herrmann N, Mazereeuw G, Goldberger K, Harimoto T, Lanctôt KL. Zinc in Depression: A Meta-Analysis. Biol Psychiatry. 2013 Nov 15;74(12):872-8.

Szewczyk B, Szopa A, Serefko A, Poleszak E, Nowak G. The role of magnesium and zinc in depression: similarities and differences. Magnes Res. 2018 Sep;31(3):78-89.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Henrique Seiji Arashiro, Lucas Dalmaso Pieroni , Gabriel de Paula Almeida , Nicolas Jose Suek Cechelero , Bruno Marques Sartori, William Simão Jatene, Augusto Haddad Nicola, Luiz Henrique Santos Vezaro , Maria Eduarda Amaral de Carvalho, Estela Merlone de Toledo, Gustavo Lazzarotto e Silva de Mello, Marcos Lourenço Spirlandelli

Downloads

Download data is not yet available.